Publications by authors named "J Chapron"

Claim this Profile
C
Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma.
Jeremy Slomka, Hugo Berthou, Audrey Mansuet-Lupo, Hélène Blons, Elizabeth Fabre, Jeanne Chapron

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.
Gary Birsen, Valérie Gounant, Nicolas Girard, Jacques Cadranel, Isabelle Monnet, Jeanne Chapron

Transl Lung Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lung cancer screening: Update, news and perspectives].
Pascal Wang, Jeanne Chapron, Souhail Bennani, Marie-Pierre Revel, Marie Wislez

Bull Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of body composition parameters on severe toxicity of nivolumab.
Laure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Audrey Thomas-Schoemann, Jeanne Chapron

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Audrey Bellesoeur, Edouard Ollier, Marie Allard, Laure Hirsch, Pascaline Boudou-Rouquette, Jeanne Chapron

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis